Affiliation:
1. Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, 06330 Ankara, Turkey
Abstract
Melanogenesis is simply defined as the production of melanin in melanosomes by melanocytes
through a complex process. Melanin, a pigment derived from L-tyrosine, comes into two
forms, namely eumelanin (brownish to black) and pheomelanin (red to yellow). Melanin synthesis
starts via the hydroxylation of L-tyrosine to L-3,4-Dihydroxyphenylalanine (DOPA) catalyzed by
the enzyme known as Tyrosinase (TYR), which triggers further conversion reaction to DOPAquinone
and then to DOPAchrome. Additionally, this process is also related to two more proteins, i.e.,
oxygenase TYR-related Protein 1 (TYRP1), and Dopachrome Tautomerase TYRP2 (or DCT).
However, TYR located in the melanosomal membrane still stands as the key enzyme to initiate the
whole process of melanogenesis. Due to some deficits, melanogenesis may emerge as hypo- or hyperpigmentation
in the skin. High production of melanin in melanocytes leads to hyperpigmentation-
related skin disorders, including freckles, melasma, melanoma, etc., that may cause displeasure
in personal appearance and reduce quality of life. Consequently, several melanogenesis inhibitors of
synthetic and natural origins have been developed up to date, though most of them have been reported
with serious side effects. For this reason, extensive research is still going on to find novel and
more effective melanogenesis inhibitors with less side effects. In this sense, particularly flavonoids,
catechins, and stilbenes from plants have been a hope to discover new inhibitors which gain significant
attention from scientists. In this review, promising natural products effective in melanogenesis
inhibition will be scrutinized.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmaceutical Science,Biotechnology